100 related articles for article (PubMed ID: 18562398)
21. Standardizing Discrete-Time Hazard Ratios With a Disease Risk Score.
Richardson DB; Keil AP; Edwards JK; Kinlaw AC; Cole SR
Am J Epidemiol; 2020 Oct; 189(10):1197-1203. PubMed ID: 32347298
[TBL] [Abstract][Full Text] [Related]
22. Identifying Drugs Inducing Prematurity by Mining Claims Data with High-Dimensional Confounder Score Strategies.
Demailly R; Escolano S; Haramburu F; Tubert-Bitter P; Ahmed I
Drug Saf; 2020 Jun; 43(6):549-559. PubMed ID: 32124266
[TBL] [Abstract][Full Text] [Related]
23. Analytic and Data Sharing Options in Real-World Multidatabase Studies of Comparative Effectiveness and Safety of Medical Products.
Toh S
Clin Pharmacol Ther; 2020 Apr; 107(4):834-842. PubMed ID: 31869442
[TBL] [Abstract][Full Text] [Related]
24. Proton Pump Inhibitors, H
Schwartz NRM; Hutfless S; Herrinton LJ; Amsden LB; Fevrier HB; Giefer M; Lee D; Suskind DL; Delaney JAC; Phipps AI
J Pediatr Pharmacol Ther; 2019; 24(6):489-496. PubMed ID: 31719810
[TBL] [Abstract][Full Text] [Related]
25. A plea to stop using the case-control design in retrospective database studies.
Schuemie MJ; Ryan PB; Man KKC; Wong ICK; Suchard MA; Hripcsak G
Stat Med; 2019 Sep; 38(22):4199-4208. PubMed ID: 31436848
[TBL] [Abstract][Full Text] [Related]
26. Controlling Confounding in a Study of Oral Anticoagulants: Comparing Disease Risk Scores Developed Using Different Follow-Up Approaches.
Bohn J; Schneeweiss S; Glynn RJ; Toh S; Wyss R; Desai R; Gagne JJ
EGEMS (Wash DC); 2019 Jul; 7(1):27. PubMed ID: 31346542
[TBL] [Abstract][Full Text] [Related]
27. Approaches to treatment effect heterogeneity in the presence of confounding.
Anoke SC; Normand SL; Zigler CM
Stat Med; 2019 Jul; 38(15):2797-2815. PubMed ID: 30931547
[TBL] [Abstract][Full Text] [Related]
28. Bias in pharmacoepidemiologic studies using secondary health care databases: a scoping review.
Prada-Ramallal G; Takkouche B; Figueiras A
BMC Med Res Methodol; 2019 Mar; 19(1):53. PubMed ID: 30871502
[TBL] [Abstract][Full Text] [Related]
29. Evaluating Community-Based Translational Interventions Using Historical Controls: Propensity Score vs. Disease Risk Score Approach.
Jiang L; Chen S; Beals J; Siddique J; Hamman RF; Bullock A; Manson SM; ;
Prev Sci; 2019 May; 20(4):598-608. PubMed ID: 30747394
[TBL] [Abstract][Full Text] [Related]
30. Marginal Structural Models for Risk or Prevalence Ratios for a Point Exposure Using a Disease Risk Score.
Richardson DB; Keil AP; Kinlaw AC; Cole SR
Am J Epidemiol; 2019 May; 188(5):960-966. PubMed ID: 30726868
[TBL] [Abstract][Full Text] [Related]
31. Association of Oral Anticoagulants and Proton Pump Inhibitor Cotherapy With Hospitalization for Upper Gastrointestinal Tract Bleeding.
Ray WA; Chung CP; Murray KT; Smalley WE; Daugherty JR; Dupont WD; Stein CM
JAMA; 2018 Dec; 320(21):2221-2230. PubMed ID: 30512099
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study.
Hicks BM; Filion KB; Yin H; Sakr L; Udell JA; Azoulay L
BMJ; 2018 Oct; 363():k4209. PubMed ID: 30355745
[TBL] [Abstract][Full Text] [Related]
33. Optimal duration for continuation of statin therapy in bacteremic patients.
Pawar AM; LaPlante KL; Timbrook TT; Caffrey AR
Ther Adv Infect Dis; 2018 Sep; 5(5):83-90. PubMed ID: 30224951
[TBL] [Abstract][Full Text] [Related]
34. Automated data-adaptive analytics for electronic healthcare data to study causal treatment effects.
Schneeweiss S
Clin Epidemiol; 2018; 10():771-788. PubMed ID: 30013400
[TBL] [Abstract][Full Text] [Related]
35. Association between nonsteroidal anti-inflammatory drugs and atrial fibrillation among a middle-aged population: a nationwide population-based cohort.
Chuang SY; Hsu PF; Lin FJ; Huang YW; Wang GZ; Chang WC; Tsai HJ
Br J Clin Pharmacol; 2018 Jun; 84(6):1290-1300. PubMed ID: 29560612
[TBL] [Abstract][Full Text] [Related]
36. Opioid Analgesic Use and Risk for Invasive Pneumococcal Diseases: A Nested Case-Control Study.
Wiese AD; Griffin MR; Schaffner W; Stein CM; Greevy RA; Mitchel EF; Grijalva CG
Ann Intern Med; 2018 Mar; 168(6):396-404. PubMed ID: 29435555
[TBL] [Abstract][Full Text] [Related]
37. Development and application of two semi-automated tools for targeted medical product surveillance in a distributed data network.
Connolly JG; Wang SV; Fuller CC; Toh S; Panozzo CA; Cocoros N; Zhou M; Gagne JJ; Maro JC
Curr Epidemiol Rep; 2017 Dec; 4(4):298-306. PubMed ID: 29204333
[TBL] [Abstract][Full Text] [Related]
38. Association of Antidepressant Medications With Incident Type 2 Diabetes Among Medicaid-Insured Youths.
Burcu M; Zito JM; Safer DJ; Magder LS; dosReis S; Shaya FT; Rosenthal GL
JAMA Pediatr; 2017 Dec; 171(12):1200-1207. PubMed ID: 29049533
[TBL] [Abstract][Full Text] [Related]
39. Making fair comparisons in pregnancy medication safety studies: An overview of advanced methods for confounding control.
Wood ME; Lapane KL; van Gelder MMHJ; Rai D; Nordeng HME
Pharmacoepidemiol Drug Saf; 2018 Feb; 27(2):140-147. PubMed ID: 29044735
[TBL] [Abstract][Full Text] [Related]
40. The Impact of Nondifferential Exposure Misclassification on the Performance of Propensity Scores for Continuous and Binary Outcomes: A Simulation Study.
Wood ME; Chrysanthopoulou S; Nordeng HME; Lapane KL
Med Care; 2018 Aug; 56(8):e46-e53. PubMed ID: 28922298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
